The short version: Creatine monohydrate at 3–5 g per day has one of the strongest safety records of any supplement studied. Its most reliable benefits for women come from pairing it with resistance training over months — lean mass, strength, and, after menopause, meaningful protection of bone density. Its effects on brain fog, mood, and menstrual cycle symptoms are mechanistically plausible and actively researched but not yet settled. And the honest headline of the whole field is that female-specific research remains thin enough that certainty in either direction would be misplaced.
This page summarizes the eight most useful pieces of research on creatine and women’s health, and then does the thing most summaries skip: identifies the patterns that show up across all of them. If you are in the research phase, the patterns are more valuable than any single study.
The eight studies worth knowing
1. Creatine across the female lifespan (2025)
The most useful single starting point. A review in the Journal of the International Society of Sports Nutrition, led by Dr. Abbie Smith-Ryan, organized around the life stages women actually move through — menstruation, pregnancy, menopause — rather than treating “women” as one category. Strongest on postmenopausal muscle and bone. Explicitly identifies pregnancy and perimenopause as the biggest evidence gaps.
2. The performance systematic review (2025)
The paper you are least likely to see quoted in a supplement ad, and the one that most improves your judgment. Researchers screened over 10,000 records and analyzed 27 studies of creatine and exercise performance in active women. Result: most showed no benefit over placebo — 3 of 11 for strength/power, 4 of 17 for anaerobic, 1 of 5 for aerobic. The authors attribute this largely to poor study design rather than a failed supplement, and still conclude active women could reasonably consider creatine.
3. Creatine beyond athletics (2025)
A narrative review asking who benefits outside sport. Its clearest finding: vegetarians and vegans have the lowest baseline stores and tend to show the largest responses, in both physical and cognitive measures. It also compares commercial creatine forms and concludes monohydrate remains the best-evidenced choice — newer forms charge more without demonstrating more.
4. Creatine, brain fog and sleep deprivation (2024)
A study in Scientific Reports gave sleep-deprived participants a single large dose (0.35 g/kg) and measured both cognitive performance and brain chemistry directly. Memory and processing speed improved, and imaging confirmed the creatine reached the brain and shifted its energy metabolism. Compelling mechanism — but 15 participants, an extreme dose, and an extreme condition.
5. Creatine and mood in women (2012)
A trial in the American Journal of Psychiatry studied 52 women with major depressive disorder, all taking an SSRI. Those who also took 5 g of creatine daily improved faster and more substantially over eight weeks, with a large effect size. Important framing: creatine was tested as an add-on to prescribed treatment, never as a replacement, and the broader literature on creatine and depression is mixed.
6. Creatine and bone density after menopause (2015)
The strongest bone finding in the literature, and one of very few 12-month supplement trials in existence. Postmenopausal women lifting weights three times weekly lost 0.5% femoral neck bone density on creatine versus 3.9% on placebo, and gained femoral shaft width, a structural marker of bone strength. The catch: the dose was roughly 10 g/day, about double what most women take.
7. The ISSN safety position stand (2017)
The formal consensus document on creatine safety. Its conclusion: no compelling evidence of harm in healthy people at recommended doses, including in studies extending to five years. Our article traces each persistent myth — hair loss, kidney damage, bloating, dehydration — back to its origin, and separates them from the few situations that genuinely warrant a doctor’s input.
8. Dr. Stacy Sims’ protocol
The practical translation. 3–5 g of creatine monohydrate daily, no loading phase, no cycling, timing irrelevant, Creapure-branded monohydrate with third-party testing, powder over gummies. Sims is an exercise physiologist focused on female-specific physiology, and creatine is one of very few supplements she recommends broadly.
Seven patterns that run through all of it
Individual studies tell you what happened once. Patterns across studies tell you what is probably true. These are the threads that connect all eight sources.
1. Creatine works with training, not instead of it
This is the most consistent finding in the entire literature, and the most commonly lost in marketing.
Every strong positive result involves resistance training. The bone trial: both groups lifted three times a week for a year. The postmenopausal lean mass findings: training plus creatine versus training alone. The lifespan review’s clearest conclusions: creatine combined with resistance training.
The performance systematic review makes the same point from the opposite direction. Nine of eleven strength studies showed improvement after supplementation — but only three beat placebo, because the placebo groups were training too. Training was doing most of the work.
Creatine is a multiplier on a stimulus, not a stimulus. If you are not doing resistance training, the research does not support expecting much from creatine. If you are, it is a reasonable addition.
2. Benefit scales with how depleted you are
Across completely unrelated research areas, the same principle appears: creatine helps most when stores are lowest or demand is highest.
- Women, who have lower baseline stores than men, are argued to be more responsive
- Vegetarians and vegans, who consume almost no dietary creatine, show the largest responses
- Sleep-deprived brains under acute energy stress showed measurable cognitive benefit
- Depression, associated with disrupted brain energy metabolism, is where the mood signal appeared
- Postmenopausal women, losing muscle and bone to declining estrogen, show the clearest life-stage benefit
This is genuinely useful for predicting your own response. A well-fed omnivore who sleeps eight hours and already trains hard has less room to gain than a plant-based woman in perimenopause who is not sleeping well. Neither should expect the other’s results.
3. Duration separates the positive studies from the null ones
Sort the research by study length and the pattern is stark.
Long studies tend to show benefit. The 12-month bone trial. Multi-month training studies measuring lean mass and strength. The eight-week mood trial.
Short studies tend to show nothing. The performance review included interventions as brief as four days, mostly measuring acute performance tests, and mostly found no placebo-controlled effect.
There is a coherent explanation. If creatine’s main contribution is letting you accumulate slightly more quality training volume, that advantage compounds over months and is nearly invisible in a five-day sprint test. The mechanism and the study-length pattern agree with each other.
Practically: judge creatine over a training block of several months. Muscle stores take three to four weeks just to saturate.
4. Dosing converges at 3–5 g — but the ceiling is unresolved
Nearly every practitioner recommendation lands on 3–5 g/day, and it is well supported: it saturates muscle stores in three to four weeks, it is well tolerated, it is cheap, and it is the dose used in the mood research.
But two of the most interesting findings used considerably more. The bone trial used ~10 g/day. The cognition study used 0.35 g/kg — roughly 24 g for a 150-pound woman — and brain uptake appears genuinely harder to achieve than muscle uptake because of the blood-brain barrier.
The honest read: 3–5 g/day is well established for muscle and may be conservative for bone and brain. The dose-response studies that would settle this in women have not been done. The performance review makes the same point, noting that creatine uptake in female muscle has not been well characterized, meaning most study doses were borrowed from male protocols.
5. Female physiology has been systematically ignored in study design
This is the structural finding, and it explains a great deal of the messiness above.
The performance systematic review appraised study quality against criteria for conducting exercise research on female bodies. Most included studies did not classify participants by reproductive status — cycle phase, contraceptive use, menopausal status. Not one met the recommendation to report detailed reproductive status data.
That matters because estrogen and progesterone appear to influence creatine kinase activity and creatine metabolism. Running a trial without accounting for where participants sit hormonally introduces noise that can bury a moderate effect.
So when you read “the evidence in women is inconclusive,” the accurate translation is usually “the studies were not designed well enough to find out,” not “it was tested properly and failed.” That distinction should shape how you weigh the null results.
6. Safety is the most settled question in the field
Amid all the uncertainty about efficacy, safety is remarkably clear. Decades of research, hundreds of trials, studies out to five years, and no compelling evidence of harm in healthy people at recommended doses.
This changes the decision calculus in a way worth stating explicitly. When a supplement is expensive, risky, or both, uncertain efficacy is a good reason to skip it. When it costs pennies a day and has one of the best safety records in the category, the bar for “worth trying” is legitimately lower. That is precisely the reasoning the performance review’s authors used to recommend creatine despite inconclusive performance findings.
The genuine exceptions are narrow and worth knowing: kidney disease, pregnancy, active endometriosis, and any prescription regimen your provider should know about. We cover each in detail.
7. Monohydrate wins, and the myths have traceable origins
Creatine monohydrate has the deepest evidence base by a wide margin. Alternative forms — HCl, ethyl ester, buffered, gummies — have not demonstrated superiority, and gummies carry real manufacturing quality concerns.
The persistent fears each trace to something identifiable: the hair loss claim to a single unreplicated study in men that measured a hormone rather than hair; the kidney fear to a misunderstanding of what blood creatinine measures; bloating to 20 g/day loading protocols nobody needs to use. Knowing the origin makes each much easier to evaluate.
Where the evidence is genuinely thin
An independent summary has to name what is missing:
- Pregnancy. Strong biological rationale, limited randomized trial data in humans. Provider territory.
- Perimenopause. Most menopause research uses clearly postmenopausal cohorts. The transition itself — arguably when symptoms peak — is nearly a blank spot.
- Menstrual cycle effects. Plausible mechanism, minimal well-designed human trials.
- Long-term women-specific outcomes. Safety at standard doses is established; multi-decade outcome data in women is not.
- Female dose-response. Nobody has properly characterized creatine uptake in female muscle, which means the standard dose is inherited rather than derived.
- Fracture outcomes. Bone density and geometry are proxies. No trial has been powered to show fewer broken bones.
What this adds up to
If you take creatine monohydrate at 3–5 g per day and do resistance training consistently, the research supports a reasonable expectation of: more lean mass and strength than training alone, meaningful protection of bone density after menopause, and a low likelihood of side effects. Possible additional benefits for cognition and mood, most likely if you are depleted, sleep-deprived, plant-based, or under stress.
What it does not support: expecting a noticeable acute performance jump, expecting results without training, or expecting a supplement to resolve a mood disorder, a sleep problem, or a bone condition on its own.
That is a modest set of claims. It is also, unusually for this industry, a set of claims that holds up.
Frequently asked questions
Should women take creatine? For women doing resistance training, the evidence supports it as a low-risk addition with reasonable expected benefit for muscle, strength, and post-menopausal bone health. The case is strongest for women who are plant-based, postmenopausal, or both.
How much creatine should a woman take? 3–5 g/day of creatine monohydrate is the standard recommendation. No loading phase is needed — that dose saturates muscle stores in about three to four weeks.
Will creatine make me gain weight or look bulky? The typical change is about a pound of water inside muscle cells, not fat, and often temporary. Muscle size is driven by training, nutrition, and hormones — not by creatine.
Does creatine work if I don’t lift weights? The strongest evidence involves resistance training. Non-training applications are areas of active research with less settled evidence.
Is creatine safe for women long-term? The ISSN position stand found no evidence of harm in healthy people at recommended doses, including studies out to five years. Kidney disease, pregnancy, and active endometriosis warrant medical input first.
What form should I buy? Creatine monohydrate, third-party tested by NSF or Informed Sport, in powder form. Skip novel forms charging a premium without evidence, and skip gummies.
Read the individual research breakdowns
- Creatine across the female lifespan: the 2025 review
- Does creatine improve performance in women? 27 studies examined
- Creatine beyond athletics: women, vegans and creatine forms compared
- Creatine and brain fog: the sleep deprivation research
- Creatine and mood in women: the depression trials
- Creatine and bone density after menopause: the 12-month trial
- Is creatine safe for women? Every myth, traced to its origin
- Dr. Stacy Sims on creatine for women: her actual protocol
Ready for the practical version?
This page covers what the research says. Our complete creatine guide for women covers what to do about it — dose, form, timing, how to read a supplement label, and how to tell a well-made monohydrate from an overpriced one.
→ Read the complete creatine guide for women
Full source list
- Smith-Ryan AE, et al. Creatine in women’s health: bridging the gap from menstruation through pregnancy to menopause. JISSN. 2025;22(1):2502094. PubMed · PMC
- Tam R, Mitchell L, Forsyth A. Does creatine supplementation enhance performance in active females? A systematic review. Nutrients. 2025;17(2):238. MDPI · PMC
- Gutiérrez-Hellín J, et al. Creatine supplementation beyond athletics: benefits of different types of creatine for women, vegans, and clinical populations. Nutrients. 2025;17(1):95. MDPI · PMC
- Gordji-Nejad A, et al. Single dose creatine improves cognitive performance and induces changes in cerebral high energy phosphates during sleep deprivation. Scientific Reports. 2024;14:4937. Nature · PubMed
- Lyoo IK, et al. A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to an SSRI in women with major depressive disorder. American Journal of Psychiatry. 2012;169(9):937-945. PubMed
- Chilibeck PD, et al. Effects of creatine and resistance training on bone health in postmenopausal women. Med Sci Sports Exerc. 2015;47(8):1587-1595. PubMed
- Kreider RB, et al. ISSN position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. JISSN. 2017;14:18. PubMed
- Smith-Ryan AE, Cabre HE, Eckerson JM, Candow DG. Creatine supplementation in women’s health: a lifespan perspective. Nutrients. 2021;13(3):877. PubMed
- Sims ST. The creatine guide for active women and Creatine FAQs for active women. drstacysims.com
Educational information only. This page summarizes published research and is not medical advice. Talk to your healthcare provider before starting any supplement, particularly if you are pregnant, breastfeeding, managing a kidney condition, or taking prescription medication.
Leave a Reply